Insights on R&D innovation, emerging technologies, competitive strategy, and strategic decision-making.
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross...
A manufacturer known for float glass and low-E coatings is quietly building the infrastructure for volume VIG production, and a...
Danone’s recent R&D activity is not only about new dairy products. It is focused on rebuilding the technical base behind...
Nearly 25% of the recent lip care innovation portfolio is not focused on incremental efficacy but on reinventing carrier systems....
39% of all EV tire innovation activity over the last two years targets winter performance, yet not a single Western...
60% of all AI-related flavor and fragrance innovations came from Chinese institutions who are filing across every technical cluster simultaneously....
While traditional players focused on incremental fortification, Mizkan Holdings, a 200-year-old vinegar company suddenly started filing hyper-specific patents on puffed...
For 30 years, salmon was the only PDRN source that mattered clinically. That assumption just broke. A December 2025 clinical study confirmed that low-molecular-weight peony...
PDRN has become one of the most watched ingredients in regenerative skincare and aesthetic medicine. For years, the competition was straightforward: who had the purest...
Two 2026 academic studies gave the cosmeceutical industry the proof it had been waiting on for years: PDRN can cross the stratum corneum. One study...
Over 90% of products marketed as “probiotic” cosmetics contain no live microorganisms. Instead, they deliver postbiotics lysates, ferments, metabolites without disclosing this substitution to consumers...
Around 12% of U.S. adults have used a GLP-1 drug such as semaglutide, tirzepatide, or a similar medication, and about 6% are using one today....
More than 35% of new skincare launches in 2024 used probiotics, prebiotics, or postbiotics. Barrier repair and hydration made up about 41% of microbiome cosmetic...
Over 40% of 2024 skincare launches featured microbiome-related ingredients. Yet approximately 90% of products labeled as “probiotic” actually contain postbiotics (ferments, lysates, filtrates) with no...
Cosmetic R&D teams are being asked to build skin microbiome portfolios while one core question remains unresolved: do barrier repair products need live bacteria, or...
An estimated 15 million U.S. adults currently use GLP-1 receptor agonist medications such as semaglutide and tirzepatide, with that figure projected to reach 30 million...
Precision fermentation is moving from early technical promise to commercial scale-up. GFI notes that fermentation-enabled protein production has expanded from a niche area into a...
Get a demo and explore how leading R&D teams use Slate to streamline discovery, stay ahead of competitors, and drive innovation.
